所有图片(1)
About This Item
线性分子式:
C6H5CH[CH(NHCH3)CH3]OH·HCl
CAS号:
分子量:
201.69
Beilstein:
3915112
EC號碼:
MDL號碼:
分類程式碼代碼:
12352103
NACRES:
NA.22
推荐产品
化驗
99%
光學活性
[α]25/D +61°, c = 1 in H2O
mp
185-188 °C (lit.)
SMILES 字串
Cl.CN[C@@H](C)[C@@H](O)c1ccccc1
InChI
1S/C10H15NO.ClH/c1-8(11-2)10(12)9-6-4-3-5-7-9;/h3-8,10-12H,1-2H3;1H/t8-,10+;/m0./s1
InChI 密鑰
BALXUFOVQVENIU-KXNXZCPBSA-N
正在寻找类似产品? 访问 产品对比指南
生化／生理作用
非选择性肾上腺素激动剂;减充血剂
Sean Ekins et al.
Drug metabolism and disposition: the biological fate of chemicals, 38(12), 2302-2308 (2010-09-17)
Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predictive in vivo, in vitro, and in silico models to identify compounds
Nigel Greene et al.
Chemical research in toxicology, 23(7), 1215-1222 (2010-06-18)
Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential
Zhichao Liu et al.
PLoS computational biology, 7(12), e1002310-e1002310 (2011-12-24)
Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI types (hepatotoxic side effects) seen in the clinic can be translated
Chromatograms
application for HPLC我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门